As the Pharma industry stands on the cusp of a new wave of improvements in health provision, the Economist Pharma Summit held in London recently explored the drivers of this change, including a new emphasis on outcomes evidence and using this to realign stakeholders around new interventions. This report provides an overview of the wide-ranging […]
written on 16.04.2014